Accesso libero

Impact of Intraoperative Cell Salvage on Circulating Tumor Cells and Cellular Activity in Patients with Hepatocellular Carcinoma Undergoing Curative Resection: A Prospective Comparative Study

, , , , ,  e   
23 giu 2025
INFORMAZIONI SU QUESTO ARTICOLO

Cita
Scarica la copertina

Ahn JC, Teng PC, Chen PJ et al. (2021) Detection of circulating tumor cells and their implications as a biomarker for diagnosis, prognostication, and therapeutic monitoring in hepatocellular carcinoma. Hepatology 73:422–436. https://doi.org/10.1002/hep.31165 AhnJC TengPC ChenPJ 2021 Detection of circulating tumor cells and their implications as a biomarker for diagnosis, prognostication, and therapeutic monitoring in hepatocellular carcinoma Hepatology 73 422 436 https://doi.org/10.1002/hep.31165 Search in Google Scholar

Aijtink VJ, Rutten VC, Meijer BEM et al. (2022) Safety of intraoperative blood salvage during liver transplantation in patients with hepatocellular carcinoma: A Systematic review and meta-analysis. Ann Surg 276:239–245. https://doi.org/10.1097/SLA.0000000000005476 AijtinkVJ RuttenVC MeijerBEM 2022 Safety of intraoperative blood salvage during liver transplantation in patients with hepatocellular carcinoma: A Systematic review and meta-analysis Ann Surg 276 239 245 https://doi.org/10.1097/SLA.0000000000005476 Search in Google Scholar

Carroll C, Young F (2021) Intraoperative cell salvage. BJA Educ 21:95–101. https://doi.org/10.1016/j.bjae.2020.11.007 CarrollC YoungF 2021 Intraoperative cell salvage BJA Educ 21 95 101 https://doi.org/10.1016/j.bjae.2020.11.007 Search in Google Scholar

Espejo-Cruz ML, González-Rubio S, Zamora-Olaya J et al. (2021) Circulating tumor cells in hepatocellular carcinoma: A comprehensive review and critical appraisal. Int J Mol Sci 22:13073. https://doi.org/10.3390/ijms222313073 Espejo-CruzML González-RubioS Zamora-OlayaJ 2021 Circulating tumor cells in hepatocellular carcinoma: A comprehensive review and critical appraisal Int J Mol Sci 22 13073 https://doi.org/10.3390/ijms222313073 Search in Google Scholar

Ganesan P, Kulik LM (2023) Hepatocellular carcinoma: New developments. Clin Liver Dis 27:85–102. https://doi.org/10.1016/j.cld.2022.08.004 GanesanP KulikLM 2023 Hepatocellular carcinoma: New developments Clin Liver Dis 27 85 102 https://doi.org/10.1016/j.cld.2022.08.004 Search in Google Scholar

Ivanics T, Shubert CR, Muaddi H et al. (2021) Blood cell salvage and autotransfusion does not worsen oncologic outcomes following liver transplantation with incidental hepatocellular carcinoma: A propensity score-matched analysis. Ann Surg Oncol 28:6816–6825. https://doi.org/10.1245/s10434-021-09863-6 IvanicsT ShubertCR MuaddiH 2021 Blood cell salvage and autotransfusion does not worsen oncologic outcomes following liver transplantation with incidental hepatocellular carcinoma: A propensity score-matched analysis Ann Surg Oncol 28 6816 6825 https://doi.org/10.1245/s10434-021-09863-6 Search in Google Scholar

Jiang Y, Han Q, Zhao H et al. (2021) Promotion of epithelial-mesenchymal transformation by hepatocellular carcinoma-educated macrophages through Wnt2b/β-catenin/c-Myc signaling and reprogramming glycolysis. J Exp Clin Cancer Res 40:13. https://doi.org/10.1186/s13046-020-01808 JiangY HanQ ZhaoH 2021 Promotion of epithelial-mesenchymal transformation by hepatocellular carcinoma-educated macrophages through Wnt2b/β-catenin/c-Myc signaling and reprogramming glycolysis J Exp Clin Cancer Res 40 13 https://doi.org/10.1186/s13046-020-01808 Search in Google Scholar

Koch DT, Yu H, Beirith I et al. (2023) Tigecycline causes loss of cell viability mediated by mitochondrial OXPHOS and RAC1 in hepatocellular carcinoma cells. J Transl Med 21:876. https://doi.org/10.1186/s12967-023-04615-4 KochDT YuH BeirithI 2023 Tigecycline causes loss of cell viability mediated by mitochondrial OXPHOS and RAC1 in hepatocellular carcinoma cells J Transl Med 21 876 https://doi.org/10.1186/s12967-023-04615-4 Search in Google Scholar

Lin D, Shen L, Luo M et al. (2021) Circulating tumor cells: Biology and clinical significance. Signal Transduct Target Ther 6:404. https://doi.org/10.1038/s41392-021-00817-8 LinD ShenL LuoM 2021 Circulating tumor cells: Biology and clinical significance Signal Transduct Target Ther 6 404 https://doi.org/10.1038/s41392-021-00817-8 Search in Google Scholar

Liu Y, Tao S, Liao L et al. (2020) TRIM25 promotes the cell survival and growth of hepatocellular carcinoma through targeting Keap1-Nrf2 pathway. Nat Commun 11:348. https://doi.org/10.1038/s41467-019-14190-2 LiuY TaoS LiaoL 2020 TRIM25 promotes the cell survival and growth of hepatocellular carcinoma through targeting Keap1-Nrf2 pathway Nat Commun 11 348 https://doi.org/10.1038/s41467-019-14190-2 Search in Google Scholar

Obore N, Liuxiao Z, Haomin Y et al. (2022) Intraoperative cell salvage for women at high risk of postpartum hemorrhage during cesarean section: A systematic review and meta-analysis. Reprod Sci 29:3161–3176. https://doi.org/10.1007/s43032-021-00824-8 OboreN LiuxiaoZ HaominY 2022 Intraoperative cell salvage for women at high risk of postpartum hemorrhage during cesarean section: A systematic review and meta-analysis Reprod Sci 29 3161 3176 https://doi.org/10.1007/s43032-021-00824-8 Search in Google Scholar

Peng C, Li X, Ao F et al. (2023) Mitochondrial ROS driven by NOX4 upregulation promotes hepatocellular carcinoma cell survival after incomplete radiofrequency ablation by inducing of mitophagy via Nrf2/PINK1. J Transl Med 21:218. https://doi.org/10.1186/s12967-023-04067-w PengC LiX AoF 2023 Mitochondrial ROS driven by NOX4 upregulation promotes hepatocellular carcinoma cell survival after incomplete radiofrequency ablation by inducing of mitophagy via Nrf2/PINK1 J Transl Med 21 218 https://doi.org/10.1186/s12967-023-04067-w Search in Google Scholar

Pinto MA, Grezzana-Filho TJM, Chedid AD et al. (2021) Impact of intraoperative blood salvage and autologous transfusion during liver transplantation for hepatocellular carcinoma. Langenbecks Arch Surg 406:67–74. https://doi.org/10.1007/s00423-020-01997-7 PintoMA Grezzana-FilhoTJM ChedidAD 2021 Impact of intraoperative blood salvage and autologous transfusion during liver transplantation for hepatocellular carcinoma Langenbecks Arch Surg 406 67 74 https://doi.org/10.1007/s00423-020-01997-7 Search in Google Scholar

Rajasekaran RB, Palmer AJR, Whitwell D et al. (2021) The role of intraoperative cell salvage for musculoskeletal sarcoma surgery. J Bone Oncol 30:100390. https://doi.org/10.1016/j.jbo.2021.100390 RajasekaranRB PalmerAJR WhitwellD 2021 The role of intraoperative cell salvage for musculoskeletal sarcoma surgery J Bone Oncol 30 100390 https://doi.org/10.1016/j.jbo.2021.100390 Search in Google Scholar

Sun B, Ji WD, Wang WC et al. (2023) Circulating tumor cells participate in the formation of microvascular invasion and impact on clinical outcomes in hepatocellular carcinoma. Front Genet 14:1265866. https://doi.org/10.3389/fgene.2023.1265866 SunB JiWD WangWC 2023 Circulating tumor cells participate in the formation of microvascular invasion and impact on clinical outcomes in hepatocellular carcinoma Front Genet 14 1265866 https://doi.org/10.3389/fgene.2023.1265866 Search in Google Scholar

Vogel A, Meyer T, Sapisochin G et al. (2022) Hepatocellular carcinoma. Lancet 400:1345–1362. https://doi.org/10.1016/S0140-6736)22)01200-4 VogelA MeyerT SapisochinG 2022 Hepatocellular carcinoma Lancet 400 1345 1362 https://doi.org/10.1016/S0140-6736)22)01200-4 Search in Google Scholar

Walton TJ, Huntley D, Whitehouse SL et al. (2023) Intraoperative cell salvage in revision hip arthroplasty. Bone Joint J 105-b:1038–1044. https://doi.org/10.1302/0301-620X.105B10.BJJ-2023-0300.R1 WaltonTJ HuntleyD WhitehouseSL 2023 Intraoperative cell salvage in revision hip arthroplasty Bone Joint J 105-b 1038 1044 https://doi.org/10.1302/0301-620X.105B10.BJJ-2023-0300.R1 Search in Google Scholar

Wang Y, Deng B (2023) Hepatocellular carcinoma: Molecular mechanism, targeted therapy, and biomarkers. Cancer Metastasis Rev 42:629–652. https://doi.org/10.1007/s10555-023-10084-4 WangY DengB 2023 Hepatocellular carcinoma: Molecular mechanism, targeted therapy, and biomarkers Cancer Metastasis Rev 42 629 652 https://doi.org/10.1007/s10555-023-10084-4 Search in Google Scholar

Weller A, Seyfried T, Ahrens N et al. (2021) Cell salvage during liver transplantation for hepatocellular carcinoma: A retrospective analysis of tumor recurrence following irradiation of the salvaged blood. Transplant Proc 53:1639–1644. https://doi.org/10.1016/j.transproceed.2021.03.025 WellerA SeyfriedT AhrensN 2021 Cell salvage during liver transplantation for hepatocellular carcinoma: A retrospective analysis of tumor recurrence following irradiation of the salvaged blood Transplant Proc 53 1639 1644 https://doi.org/10.1016/j.transproceed.2021.03.025 Search in Google Scholar

Yang X, Yang C, Zhang S et al. (2024) Precision treatment in advanced hepatocellular carcinoma. Cancer Cell 42:180–197. https://doi.org/10.1016/j.ccell.2024.01.007 YangX YangC ZhangS 2024 Precision treatment in advanced hepatocellular carcinoma Cancer Cell 42 180 197 https://doi.org/10.1016/j.ccell.2024.01.007 Search in Google Scholar

Lingua:
Inglese
Frequenza di pubblicazione:
1 volte all'anno
Argomenti della rivista:
Medicina, Scienze medicali di base, Biochimica, Immunologia, Medicina clinica, Medicina clinica, altro, Chimica clinica